ClinicalTrials.Veeva

Menu

Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus

University of Oklahoma (OU) logo

University of Oklahoma (OU)

Status and phase

Completed
Phase 2

Conditions

Diabetes Mellitus, Adult Onset

Treatments

Drug: Cinnamon or placebo 500 mg capsule twice daily

Study type

Interventional

Funder types

Other
NIH

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine the effects of cinnamon on serum glucose and lipid levels in people with non-insulin dependent type 2 diabetes mellitus.

Full description

Forty people with non-insulin dependent type 2 diabetes mellitus will be randomized to receive either cinnamon or placebo for three months. The dose of cinnamon will be one gram daily. Fasting serum glucose, triglyceride, total cholesterol, LDL, HDL, and insulin levels will be measured at baseline and at 1, 2, and 3 months. HbA1c levels will be measured at baseline and at 3 months. Patients will be monitored for compliance, adverse effects, and dietary changes.

Enrollment

85 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 diabetes mellitus
  • HbA1C > 6.0%
  • Age 18 and above
  • Able to obtain consent

Exclusion criteria

  • Currently taking insulin
  • Pregnancy
  • End-stage renal disease
  • Hemolytic anemia
  • Cinnamon intolerance
  • Inability or unwillingness to adhere to study protocol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

85 participants in 2 patient groups, including a placebo group

1
Placebo Comparator group
Treatment:
Drug: Cinnamon or placebo 500 mg capsule twice daily
2
Active Comparator group
Treatment:
Drug: Cinnamon or placebo 500 mg capsule twice daily

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems